Antibodies and antigen-binding fragments of antibodies that bind human CXCR3 are disclosed. In preferred embodiments, the antibodies are human. Nucleic acids and vectors encoding the antibodies or portions thereof, recombinant cells that contain the nucleic acids, and compositions comprising the antibodies or antigen-binding fragments are also disclosed. The invention also provides therapeutic and diagnostic methods which employ the antibodies and antigen-binding fragments.

 
Web www.patentalert.com

< Process for ex vivo formation of mammalian bone and uses thereof

> Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss

~ 00450